Sino Biological deposits recombinant Omicron proteins and antibodies to BEI Resources

Posted: 14 January 2022 | | No comments yet

To support disease research, Sino Biological has deposited reagents for the Omicron variant to BEI Resources.

Omicron reagent

Credit: Sino Biological

Sino Biological has announced that it has recently deposited reagents for the Omicron variant, including recombinant proteins to Spike and Nucleocapsid, and antibody products to BEI Resources, a central repository for reagents to support infectious disease research. With the addition of the Omicron products to previously deposited array of SARS-CoV-2 reagents, researchers can readily get access to them by registering with BEI Resources.

The table below lists the five Omicron products that will be available in BEI Resources.

BEI Item #

Sino Item #




SARS-CoV-2 B.1.1.529 (Omicron) Spike RBD Protein (His Tag)



 SARS-CoV-2 Spike Antibody, Omicron Reactive, Mouse MAb



SARS-CoV-2 B.1.1.529 (Omicron) Nucleocapsid Protein (His Tag)



SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein (ECD, His Tag)



SARS-CoV-2 B.1.1.529 (Omicron) Spike S1 Protein (His Tag)

Sino Biological is an international biological reagent supplier and service provider. The company specialises in recombinant antigen production and antibody development. The company’s ever-growing portfolio of products includes over 6,000 recombinant proteins, 13,000 antibodies, ELISA assay kits, expression clones, cell culture media and other molecular biology tools. The company also offers a variety of customised services, mainly focusing on recombinant production of antigens and antibodies. Sino Biological is dedicated to virology and infectious disease research. Its newly launched ProVirTM collection is the world’s largest viral antigen bank, carrying over 1,000 viral products from 350 strains of viruses.

Related conditions

Related organisations